We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) DOPTELET avatrombopag 20 mg film-coated tablets (Germany)
Section 19A approved medicine
(Approval lapsed) DOPTELET avatrombopag 20 mg film-coated tablets (Germany)
Section 19A approval holder
Swedish Orphan Biovitrum Pty Ltd ABN 14 645 396 532
Phone
1800 570 605
Approved until
Status
Expired
Medicines in short supply/unavailable
DOPTELET avatrombopag (as maleate) 20 mg film-coated tablets blister pack - ARTG 375471
Indication(s)
- for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.
- for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.
Images
